Daito Pharmaceutical ,Ltd. Profit Margin

The latest profit margin for 4577.T is 6.39% as of August 2026. That compares with 3.9% in the prior-year period — up 64.0% year over year. That is below the sector sector average of 13.23%. Investors often review this figure alongside Daito Pharmaceutical ,Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 4577.T's profit margin moved from 3.9% to 6.39% — a 64.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Daito Pharmaceutical ,Ltd.'s valuation or profitability profile.

Against its sector companies, 4577.T currently prints 6.39% for profit margin, while the sector average sits near 13.23%. That is roughly 51.7% below the sector mean. Large gaps often invite a closer look at Daito Pharmaceutical ,Ltd.'s growth, margins, and balance sheet.

Profit Margin shows how effectively Daito Pharmaceutical ,Ltd. converts resources into returns. At 6.39%, 4577.T may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 3.9% in the prior-year period — up 64.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 4577.T's profit margin (6.39%), review year-over-year change from 3.9%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.